|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | -33.33% |
|
-.--% | -66.67% |
| 2023 | Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes | CI |
| 2023 | Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes | CI |
Tengjun Biotechnology Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 150.14 million.
Net income was USD 11.35 million compared to net loss of USD 0.747525 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 201M | |
| +33.10% | 68.21B | |
| +56.67% | 38.32B | |
| +37.54% | 9.99B | |
| +2.48% | 6.87B | |
| +3.21% | 5.42B | |
| +5.06% | 4.72B | |
| -5.07% | 3.36B | |
| +19.78% | 2.76B | |
| -7.22% | 2.53B |
TENGJUN BIOTECHNOLOGY CORP. 
